1. Home
  2. SLRX vs AIHS Comparison

SLRX vs AIHS Comparison

Compare SLRX & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLRX
  • AIHS
  • Stock Information
  • Founded
  • SLRX N/A
  • AIHS 2014
  • Country
  • SLRX United States
  • AIHS China
  • Employees
  • SLRX N/A
  • AIHS N/A
  • Industry
  • SLRX Biotechnology: Pharmaceutical Preparations
  • AIHS Finance: Consumer Services
  • Sector
  • SLRX Health Care
  • AIHS Finance
  • Exchange
  • SLRX Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • SLRX 2.9M
  • AIHS 3.0M
  • IPO Year
  • SLRX N/A
  • AIHS 2018
  • Fundamental
  • Price
  • SLRX $5.29
  • AIHS $2.14
  • Analyst Decision
  • SLRX
  • AIHS
  • Analyst Count
  • SLRX 0
  • AIHS 0
  • Target Price
  • SLRX N/A
  • AIHS N/A
  • AVG Volume (30 Days)
  • SLRX 129.8K
  • AIHS 9.0M
  • Earning Date
  • SLRX 11-13-2025
  • AIHS 11-13-2025
  • Dividend Yield
  • SLRX N/A
  • AIHS N/A
  • EPS Growth
  • SLRX N/A
  • AIHS N/A
  • EPS
  • SLRX N/A
  • AIHS N/A
  • Revenue
  • SLRX N/A
  • AIHS $3,370,162.00
  • Revenue This Year
  • SLRX N/A
  • AIHS N/A
  • Revenue Next Year
  • SLRX N/A
  • AIHS N/A
  • P/E Ratio
  • SLRX N/A
  • AIHS N/A
  • Revenue Growth
  • SLRX N/A
  • AIHS 8.56
  • 52 Week Low
  • SLRX $4.50
  • AIHS $1.84
  • 52 Week High
  • SLRX $108.00
  • AIHS $17.00
  • Technical
  • Relative Strength Index (RSI)
  • SLRX 39.91
  • AIHS 44.27
  • Support Level
  • SLRX $4.50
  • AIHS $2.08
  • Resistance Level
  • SLRX $5.65
  • AIHS $8.26
  • Average True Range (ATR)
  • SLRX 0.40
  • AIHS 0.72
  • MACD
  • SLRX 0.18
  • AIHS 0.00
  • Stochastic Oscillator
  • SLRX 44.38
  • AIHS 1.61

About SLRX Salarius Pharmaceuticals Inc.

Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. Along with its subsidiaries, it is engaged in facilitating automobile transactions and offering related services. The group's business activities include providing car rental services to individual customers with lease term no more than twelve months; leasing and servicing of new energy vehicles; offering services to automobile purchasers throughout the purchase process; providing management and related services to Partner Platforms and other companies; automobile financing; and providing other related supporting services to customers. The majority of the group's revenue is generated from its automobile rental business.

Share on Social Networks: